◆英語タイトル：Virbac Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3496
◆発行会社（調査会社）：
MarketLine
◆発行日：2019
◆ページ数：26
◆レポート言語：
◆レポート形式：PDF
◆納品方法：E
◆対象地域：
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Virbac Corporation – Strategy, SWOT and Corporate Finance Report
Summary
Virbac Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Virbac Corporation (Virbac or ‘the company’), a subsidiary of Virbac SA, is engaged in the manufacturing and marketing of animal health and pet care products. Virbac offers products for antibiotics, behavior, dental, dermatology, digestive, hormone, antibiotics, parasiticides, supplements and urinary. Under Anxitane, Novifit, C.e.t, Hextra, Orastrip, Veggiedent, Allergroom brands among others. The company primarily operates in the US where it is headquartered in Fort Worth, Texas, the US.
Scope
- Detailed information on Virbac Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Virbac Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Virbac Corporation including a breakdown and examination of key business segments
- Intelligence on Virbac Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Virbac Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Virbac Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Virbac Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Virbac Corporation’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
Virbac Corporation: Company Overview
Virbac Corporation: Overview and Key Facts
Virbac Corporation: Overview
Virbac Corporation: Key Facts
Virbac Corporation: Key Employees
Virbac Corporation: Key Employee Biographies
Virbac Corporation: Major Products and Services
Virbac Corporation: Company History
Virbac Corporation: Management Statement
Virbac Corporation: Locations and Subsidiaries
Virbac Corporation: Key Competitors
Virbac Corporation: Company Analysis
Virbac Corporation: Business Description
Virbac Corporation: SWOT Analysis
Virbac Corporation: SWOT Overview
Virbac Corporation: Strengths
Virbac Corporation: Weaknesses
Virbac Corporation: Opportunities
Virbac Corporation: Threats
Virbac Corporation: Corporate Financial Deals Activity
Virbac Corporation: Financial Deals Overview
Virbac Corporation: Top Deals 2015 – 2019YTD*
Virbac Corporation: Divestments
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Virbac Corporation: Key Facts
Table 2: Virbac Corporation: Key Employees
Table 3: Virbac Corporation: Company History
Table 4: Virbac Corporation: Locations and Subsidiaries
Table 5: Virbac Corporation: Key Competitors
Table 6: Virbac Corporation: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Virbac Corporation: Top Deals 2015 - 2019YTD*
Table 8: Virbac Corporation: Divestments Volume and Value Trend (2015 - YTD*2019)
